Insulin detemir

Learn about Insulin detemir, a long-acting insulin used to manage blood sugar in type 1 and type 2 diabetes. Understand its uses, dosage, and side effects.

Insulin detemir Insulin detemir uses Insulin detemir dosage Insulin detemir side effects Long-acting insulin for diabetes Levemir medication Type 1 diabetes treatment Type 2 diabetes treatment Blood sugar control
🏷 ATC Code: A10AE05 📂 Insulins and analogues for injection, long-acting 🕐 Updated: Mar 12, 2026 ✓ Medical Reference

Looking to order Insulin detemir?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Insulin Detemir?

Insulin detemir is a synthetic, long-acting human insulin analogue prescribed to help manage blood sugar levels in individuals with diabetes. It is a modified form of human insulin designed to provide a steady, prolonged release of insulin over many hours, mimicking the body's natural basal insulin production. This medication is commonly known by its brand name, Levemir.

Used in both type 1 and type 2 diabetes mellitus, Insulin detemir helps the body utilize glucose for energy and store excess glucose for future use. For people with type 1 diabetes, it is an essential part of their daily treatment regimen, as their pancreas produces little to no insulin. In type 2 diabetes, where the body may not produce enough insulin or effectively use the insulin it produces, Insulin detemir helps to supplement the body's natural insulin supply and improve overall glycemic control.

How Does it Work?

The mechanism of action for Insulin detemir is designed to provide a smooth and consistent effect on blood glucose levels. Unlike rapid-acting insulins, which are quickly absorbed and have a short duration, Insulin detemir is engineered for prolonged action. This is achieved through several structural modifications:

  • Fatty Acid Chain: A fatty acid chain is attached to the insulin molecule, which allows it to bind reversibly to albumin, a protein in the blood. This binding slows down its distribution and degradation, extending its half-life.
  • Self-Association: Once injected, Insulin detemir molecules self-associate at the injection site, forming hexamers. These hexamers slowly dissociate into monomers, which are then absorbed into the bloodstream.
  • Slow Absorption: The combination of albumin binding and self-association results in a slow and sustained release of insulin into the circulation. This provides a relatively peakless profile, meaning it maintains a steady concentration in the body for an extended period, typically up to 24 hours.

By providing a constant basal level of insulin, Insulin detemir helps to regulate blood sugar between meals and overnight, preventing excessive rises in glucose and reducing the risk of nocturnal hypoglycemia.

Medical Uses

Insulin detemir is approved for the following medical uses:

  • Type 1 Diabetes Mellitus: It is used in adults and children (1 year and older) to improve glycemic control. It is typically administered once or twice daily as part of a multi-dose insulin regimen, often in combination with a rapid-acting insulin taken at mealtimes.
  • Type 2 Diabetes Mellitus: It is used in adults and children (2 years and older) to improve glycemic control. It can be used alone or in combination with oral antidiabetic medications or other injectable therapies.

It is important to note that Insulin detemir is not intended for the treatment of diabetic ketoacidosis (DKA), an acute and serious complication of diabetes. For DKA, rapid-acting insulin administered intravenously is typically required.

Dosage

The dosage of Insulin detemir is highly individualized and must be determined by a healthcare professional based on the patient's specific needs, blood glucose monitoring results, and overall treatment plan. It is administered by subcutaneous injection, usually once or twice daily.

  • Once-Daily Dosing: If administered once daily, it should be given with the evening meal or at bedtime, or with the morning meal.
  • Twice-Daily Dosing: If administered twice daily, the evening dose can be given either with the evening meal, at bedtime, or 10-12 hours after the morning dose.
  • Administration: Insulin detemir should be injected into the fatty tissue just under the skin (subcutaneously) in the abdomen, thigh, or upper arm. Injection sites should be rotated to prevent lipodystrophy (changes in fat tissue).

Patients should be educated on proper injection technique, storage of insulin, and the importance of consistency in administration time. Never share insulin pens or syringes with others, even if the needle is changed, as this poses a risk of transmitting infections.

Side Effects

Like all medications, Insulin detemir can cause side effects. The most common and significant side effect is hypoglycemia (low blood sugar), which can range from mild to severe. Symptoms of hypoglycemia include dizziness, sweating, confusion, headache, blurred vision, hunger, irritability, and rapid heartbeat. Severe hypoglycemia can lead to seizures, unconsciousness, and even death if not promptly treated.

Other common side effects may include:

  • Injection site reactions: Redness, swelling, itching, or pain at the injection site. These are usually mild and temporary.
  • Weight gain: Insulin therapy can sometimes lead to weight gain.
  • Peripheral edema: Swelling in the hands, ankles, or feet.
  • Lipodystrophy: Changes in fat tissue at the injection site (e.g., lumps or indentations) if sites are not rotated.

Less common but serious side effects include severe allergic reactions (anaphylaxis), which require immediate medical attention. Symptoms may include rash over the entire body, shortness of breath, wheezing, rapid pulse, or sweating.

Drug Interactions

Several medications can interact with Insulin detemir, potentially altering its effects on blood glucose levels. It is crucial to inform your doctor about all medications, supplements, and herbal products you are currently taking.

  • Drugs that may increase the hypoglycemic effect: Oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogues (e.g., octreotide), sulfonamide antibiotics.
  • Drugs that may decrease the hypoglycemic effect: Corticosteroids, danazol, diuretics, estrogen, oral contraceptives, phenothiazines, somatropin, sympathomimetics (e.g., epinephrine, salbutamol, terbutaline), thyroid hormones.
  • Beta-blockers: These medications can mask the symptoms of hypoglycemia, making it harder to recognize when blood sugar is dangerously low.
  • Alcohol: Alcohol can either potentiate or reduce the hypoglycemic effect of insulin, and should be consumed with caution and in moderation.
  • Thiazolidinediones (TZDs): When used in combination with insulin, TZDs can increase the risk of fluid retention and heart failure, especially in patients with pre-existing heart conditions.

Always discuss potential drug interactions with your healthcare provider to ensure safe and effective diabetes management.

FAQ

Q: Is Insulin detemir the same as Levemir?

A: Yes, Levemir is the brand name for the drug substance Insulin detemir.

Q: How quickly does Insulin detemir start working?

A: Insulin detemir has a gradual onset of action, typically starting to lower blood sugar within 1-2 hours after injection, with its peakless effect lasting up to 24 hours.

Q: Can Insulin detemir be mixed with other insulins?

A: Generally, Insulin detemir should not be mixed with other insulins or solutions. Mixing can alter its prolonged action profile and effectiveness. Always follow your doctor's specific instructions.

Q: What should I do if I miss a dose of Insulin detemir?

A: If you miss a dose, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one, as this can lead to severe hypoglycemia. Consult your healthcare provider for specific advice.

Q: How should Insulin detemir be stored?

A: Unopened Insulin detemir should be stored in a refrigerator (2°C to 8°C). Once opened or in-use, it can be stored at room temperature (below 30°C) for up to 42 days (6 weeks). Do not freeze insulin, and protect it from light and excessive heat.

Products containing Insulin detemir are available through trusted online pharmacies. You can browse Insulin detemir-based medications at ShipperVIP or Medicenter.

Summary

Insulin detemir is a vital long-acting insulin analogue used to provide basal insulin replacement for individuals with type 1 and type 2 diabetes. Its unique formulation allows for a steady, sustained release, effectively managing blood glucose levels between meals and overnight. While highly effective, proper administration, careful monitoring for hypoglycemia, and awareness of potential drug interactions are crucial for its safe and successful use. Always work closely with your healthcare provider to tailor your insulin regimen and address any concerns, ensuring optimal diabetes management and overall well-being.